Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR)

Diabetes and Metabolism

Volumn 35, Issue 6, 2009, Pages 439-446

  Nilsson, P M ^a   Cederholm, J ^b   Eeg Olofsson, K ^c   Eliasson, B ^c   Zethelius, B ^b   Gudbjornsdottir S ^c  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Diabetes; Epidemiology; Myocardial infarction; Pulse pressure

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC PATIENT; DISEASE DURATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PULSE PRESSURE; RISK ASSESSMENT; STROKE;

AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; HEART RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; REGRESSION ANALYSIS; RISK; SWEDEN;

EID: 71149111694     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.04.010     Document Type: Article

References (41)

1. Haffner S., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
2. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Diabetes Care 16 (1993) 434-444
3. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type II diabetes: UKPDS 38. BMJ 317 (1998) 703-712
4. Stehouwer C.D.A., Henry R.M.A., and Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 51 (2008) 527-539
5. Aoun S., Blacher J., Safar M.E., and Mourad J.J. Diabetes mellitus and renal failure: effects on large artery stiffness. J Hum Hypertens 15 (2001) 693-700
6. Ravikumar R., Deepa R., Shanthirani C., and Mohan V. Comparison of carotid intima-media thickness, arterial stiffness,and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 90 (2002) 702-707
7. Schram M.T., Henry R.M., van Dijk R.A., Kostense P.J., Dekker J.M., Nijpels G., et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 43 (2004) 176-181
8. Bella J.N., Devereux R.B., Roman M.J., Palmieri V., Liu J.E., Paranicas M., et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 87 (2001) 1260-1265
9. Safar M.E., London G.M., for the Clinical Committee of Arterial Structure and Function, and on behalf of the Working Group on Vascular Structure Function of the European Society of Hypertension. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 18 (2000) 1527-1535
10. Schiffrin E.L. Vascular stiffness and arterial compliance. Implications for Systolic Blood Pressure. Am J Hypertens 17 (2004) 39S-48S
11. Mokhtari A., Bellinetto-Ford L., Melander O., and Nilsson P.M. Determinants of increasing pulse pressure during 23 years' follow-up as a marker of arterial stiffness and vascular ageing. Blood Press 17 (2008) 291-297
12. Schram M.T., Kostense P.J., Van Dijk R.A., Dekker J.M., Nijpels G., Bouter L.M., et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 20 (2002) 1743-1751
13. Cockcroft J.R., Wilkinson I.B., Evans M., McEwan P., Peters J.R., Davies S., et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 18 (2005) 1463-1467
14. Gudbjörnsdottir S., Cederholm J., Nilsson P.M., and Eliasson B. The National Diabetes Register in Sweden: An implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26 (2003) 1270-1276
15. Nilsson P.M., Gudbjörnsdottir S., Eliasson B., Cederholm J., for the Steering Committee of the National Diabetes Register, and Sweden. Hypertension in diabetes - trends in control and relation to macrovascular morbidity in repeated national surveys from Sweden. J Hum Hypertens 17 (2003) 37-44
16. Eliasson B., Cederholm J., Nilsson P., Gudbjörnsdottir S., and for the steering committee of the Swedish National Diabetes Register. The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996-2003. Diabet Med 22 (2005) 1420-1426
17. Eeg-Olofsson K., Cederholm J., Nilsson P.M., Zethelius B., Gudbjörnsdóttir S., Eliasson B., et al. Overweight, obesity and cardiovascular diseases and mortality in type 2 diabetes: an observational study in 13 087 patients. Diabetologia 52 (2009) 65-73
18. Cederholm J., Eeg-Olofsson K., Eliasson B., Zethelius B., Nilsson P.M., Gudbjörnsdottir S., and on behalf of the Swedish National Diabetes Register. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register (NDR). Diabetes Care 31 (2008) 2038-2043
19. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 1 (2004) 166-174
20. Merlo J., Lindblad U., Pessah-Rasmussen H., Hedblad B., Rastam J., and Isacsson S.O. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16 (2000) 235-243
21. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A., and Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, events rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994) 583-612
22. Spiegelman D., Hertzmark E., and Wand H.C. Point and interval estimates of partial population-attributable risks in cohort studies: examples and software. Cancer Causes Control 18 (2007) 571-579
23. Darne B., Girerd X., Safar M., Cambien F., and Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13 (1989) 392-400
24. Vaccarino V., Holford T.R., and Krumholz H.M. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36 (2000) 130-138
25. Madhavan S., Ooi W.L., Cohen H., and Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 23 (1994) 395-401
26. Benetos A., Safar M., Rudnichi A., Smulyan H., Richard J.L., and Ducimetiere P. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30 (1997) 1410-1415
27. Alderman M.H., Cohen H., and Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 16 (1998) 761-769
28. Mitchell G.F., Moye L.M., Braunwald E., Rouleau J.-L., Bernstein V., Geltman E.M., et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation 96 (1997) 4254-4260
29. Roman M.J., Ganau A., Saba P.S., Pini R., Pickering T.G., and Devereux R.B. Impact of arterial stiffening on left ventricular structure. Hypertension 36 (2000) 489-494
30. Boutouyrie P., Tropeano A.I., Asmar R., Gautier I., Benetos A., and Lacolley P. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39 (2002) 10-15
31. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Ducimetiere P., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
32. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., and Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 106 (2002) 2085-2090
33. In: Nichols W.W., and O'Rourke M.F. (Eds). McDonald's blood flow in arteries. Theoretical, experimental and clinical principles. 4th ed. (1998), Arnold, London
34. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 15 (1990) 339-347
35. Pedrinelli R., Dell'Omo G., Penno G., Bandinelli S., Bertini A., Di Bello V., et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 35 (2000) 48-54
36. Cameron J.D., and Dart A.M. Exercise training increases total systemic arterial compliance in humans. Am J Physiol 266 (1994) H693-H701
37. Safar M., Laurent S., Safavian A., Pannier B., and Asmar R. Sodium and large arteries in hypertension. Effects of indapamide. Am J Med 84 (1988) 15-19
38. Nestel P.J., Pomeroy S.E., Sasahara T., Yamashita T., Liang Y.L., Dart A.M., et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 17 (1997) 1163-1170
39. Dart A.M., and Kingwell B.A. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 37 (2001) 975-984
40. Davis J., Gavin A., Band M., Morris A., and Struthers A. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol 59 (2005) 520-523
41. Mourad J.-J., Pannier B., Blacher J., Rudnichi A., Benetos A., London G.M., et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int. 59 (2001) 1834-1841